Clinical Trials Logo

Vascular Diseases, Peripheral clinical trials

View clinical trials related to Vascular Diseases, Peripheral.

Filter by:
  • None
  • Page 1

NCT ID: NCT06366763 Recruiting - Clinical trials for Varicose Veins of Lower Limb

Comparative Clinical Efficacy Between Multi-layer Bandage Pressure Therapy and Gradient Pressure Elastic Stocking Treatment After Endovenous Radiofrequency Ablation

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Objective: To assess the clinical efficacy of different compression methods within 48 hours after endovenous radiofrequency ablation (RFA) in terms of great saphenous vein closure rate, postoperative complications, quality of life, time to return to normal work, and patient satisfaction.

NCT ID: NCT05654233 Not yet recruiting - Clinical trials for Varicose Veins of Lower Limb

The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether adding sulodexide to the patients with varicose veins who received radiofrequency ablation combined with sclerotherapy can reduce or improve the impact of adverse events。

NCT ID: NCT04765566 Completed - Clinical trials for Vascular Diseases, Peripheral

FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

Start date: February 5, 2021
Phase:
Study type: Observational

This is a retrospective, multi-center study to assess the safety and performance by proactively reviewing pre-existing medical records and imaging of patients who had previous placement of FLUENCY® PLUS Vascular Stent Graft in iliac artery vessel(s) between January 2010 and March 2020.

NCT ID: NCT04645771 Recruiting - Clinical trials for Varicose Veins of Lower Limb

Safety and Efficacy Study of Endovenous Microwave Ablation for Treatment of Varicose Veins

EMINENCE
Start date: February 4, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of microwave ablation catheter in the treatment of varicose veins in lower extremities,meanwhile, to compare the quality of subjects'lives before and after treatment.

NCT ID: NCT04089943 Recruiting - Atherosclerosis Clinical Trials

The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD

Start date: September 15, 2019
Phase: N/A
Study type: Interventional

MicroRNA-210 (miR-210) can be a potential therapeutic target of patients with peripheral artery disease (PAD). Recent evidence suggests the role of miR-210 and oxidative stress in the pathophysiology of PAD and its association with mitochondrial function, oxidative metabolism, walking distances and quality of life. The protocol evaluates the mechanisms which miR-210 regulates oxidative stress and provides evidence of potential therapeutic strategies.